{"id":"W2051365306","doi":"10.1007/s00280-009-1064-z","title":"A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada); Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"Eli Lilly Canada","keywords":"Gemcitabine; Pemetrexed; Medicine; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Phases of clinical research; Antimetabolite; Cancer; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001888938,0.001725549,0.003787614,0.0007905882,0.0007141522,0.001260758,0.001459763,0.002051762,0.005325434],"category_scores_gemma":[0.001438809,0.001166249,0.001893954,0.0008285195,0.001568969,0.001984695,0.0006226212,0.005882959,0.001307911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001189934,"about_ca_system_score_gemma":0.002197705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001926265,"about_ca_topic_score_gemma":0.004037339,"domain_scores_codex":[0.9992169,0.0003997629,0.00003556761,0.000139869,0.00004570788,0.0001620704],"domain_scores_gemma":[0.9986947,0.0002708697,0.0001689408,0.0001551418,0.00005299607,0.0006574289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8762735,0.07061214,0.002001318,0.0003284446,0.0007192519,0.00008466776,0.0001975356,0.001268058,0.01037182,0.0001265083,0.001050926,0.03696594],"study_design_scores_gemma":[0.6784387,0.3145831,0.004188565,0.00001528237,0.0002744575,0.00007351104,0.00006047944,0.0004397458,0.0008626975,0.00009203079,0.0009510083,0.00002042479],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935648,0.001768871,0.0003806177,0.0005137261,0.0001710171,0.001612799,0.0005739898,0.00006864712,0.00134553],"genre_scores_gemma":[0.9883721,0.002501919,0.001510384,0.0007815598,0.000307657,0.002412071,0.001299032,0.00004046511,0.002774804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005325434,"threshold_uncertainty_score":0.01781535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01661380561238993,"score_gpt":0.3590211715198569,"score_spread":0.3424073659074669,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}